Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


- An 'Oncolytic’ (cancer killing) adenovirus is being developed to selectively infect and kill cancer cells!

- Unlike most gene therapy vectors, this virus is equipped to make copies of itself in infected cancer cells and destroy them.

- By deleting adenovirus genes required for replication in normal cells, this oncolytic virus is made tumour-specific!


This is one example of how researchers are taking advantage of adenovirus to treat disease.

 Adenoviral vectors:

  • Effective and efficient short-term and immunogenic expression.
  • Relatively large gene capacity.
  • Easy to produce high quantities.


 Click here to discover how an adenoviral vector is used to vaccinate against COVID-19!



Other viral vectors are also being used or developed to treat disease: 




Find out more about the work of the Gill Hyde Gene Medicine research group at the University of Oxford.